Sponsor Pipeline

Beam Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
4
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1/2
4
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06735755 A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in… Glycogen Storage Disease Type Ia Recruiting
NCT06389877 A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1… Alpha 1-Antitrypsin Deficiency Recruiting
NCT05885464 A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell… Lymphoblastic Lymphoma Active, Not Recruiting
NCT05456880 BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe… Sickle Cell Disease Active, Not Recruiting
Phase 1
NCT07304791 This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the… Healthy Subjects Recruiting
Not specified
NCT07373639 A Long-term Follow-up Study in Patients Who Received BEAM-101 Hemoglobinopathy Recruiting
Disease Areas
Get alerts when Beam Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free